Dietary Supplementation With Nonfermentable Fiber Alters the Gut Microbiota and Confers Protection in Murine Models of Sepsis.
Dietary Supplementation With Nonfermentable Fiber Alters the Gut Microbiota and Confers Protection in Murine Models of Sepsis.
复制标题
DOI:
10.1097/ccm.0000000000002291
复制
发表时间:
2017-05
影响因子:
8.8
通讯作者:
Aneja RK
中科院分区:
文献类型:
--
作者:
Morowitz MJ;Di Caro V;Pang D;Cummings J;Firek B;Rogers MB;Ranganathan S;Clark RSB;Aneja RK
Links between microbial alterations and systemic inflammation have been demonstrated in chronic disease, but little is known about these interactions during acute inflammation. This study investigates the effect of dietary supplementation with cellulose, a nonfermentable fiber, on the gut microbiota, inflammatory markers, and survival in two murine models of sepsis. Prospective experimental study. University laboratory. Subjects: 6 week old male C57BL/6 wild-type mice. Mice were assigned to low-fiber (LF), normal-fiber (NF), or high-fiber (HF) diets with or without antibiotics for two weeks and then subjected to sepsis by cecal ligation and puncture (CLP) or endotoxin injection. Fecal samples were collected for microbiota analyses before and after dietary interventions. Mice that received a HF diet demonstrated increased survival after CLP relative to mice receiving LF or NF diets. The survival benefit was associated with decreased serum concentration of pro-inflammatory cytokines, reduced neutrophil infiltration in the lungs, and diminished hepatic inflammation. The HF diet also increased survival after endotoxin injection. Bacterial 16S rRNA gene sequences from each sample were amplified, sequenced, and analyzed. Fiber supplementation yielded an increase in relative abundance of the genera Akkermansia and Lachnospiraceae, taxa commonly associated with metabolic health. Administration of antibiotics to mice on the HF diet negated the enrichment of Akkermansia species and the survival benefit after CLP. Dietary supplementation with cellulose offers a microbe-mediated survival advantage in murine models of sepsis. Improved understanding of the link between diet, the microbiota, and systemic illness may yield new therapeutic strategies for patients with sepsis.